Mia's Feed
Medical News & Research

Innovative Drug Protects Blood-Brain Barrier: A Breakthrough in Alzheimer's Treatment

Innovative Drug Protects Blood-Brain Barrier: A Breakthrough in Alzheimer's Treatment

Share this article

Researchers have discovered a novel drug that protects the blood-brain barrier and shows promise in preventing Alzheimer's-related neurodegeneration, offering a new approach beyond traditional treatments.

2 min read

Recent research has uncovered a promising new approach to combating Alzheimer's disease by focusing on maintaining the integrity of the blood-brain barrier (BBB), a vital protective layer that shields the brain from harmful substances. Scientists at Case Western Reserve University, in collaboration with University Hospitals and the Louis Stokes Cleveland VA Medical Center, have identified a novel drug that effectively preserves BBB function and prevents neurodegeneration in mouse models of Alzheimer's disease (AD).

The study, published in the journal Proceedings of the National Academy of Sciences on May 21, 2025, highlights the importance of targeting the BBB—a departure from traditional strategies that primarily focus on neurons. The research reveals that deterioration of the BBB is an early warning sign of neurodegenerative conditions like AD and traumatic brain injury (TBI). The enzyme 15-PGDH, highly enriched in the BBB and found to be elevated in AD, TBI, and aging in both mice and humans, emerged as a key target.

A drug called SW033291, developed at Case Western Reserve University and University Hospitals, was used to inhibit the enzyme 15-PGDH. Originally designed to activate stem cells for tissue repair, this drug was found to also protect the BBB and reduce brain inflammation without altering amyloid levels—the sticky protein commonly associated with AD. This is significant because current treatments largely aim to remove amyloid but often face limited success and potential side effects.

Remarkably, administering SW033291 even a day after brain injury in mice prevented neurodegeneration and cognitive decline, suggesting potential for therapeutic use in brain injuries, neurodegenerative diseases, and aging-related conditions. The research team, led by co-senior researchers Andrew Pieper and Sanford Markowitz, emphasizes the novelty of focusing on the BBB as a therapeutic target, opening new avenues for drug development in neurodegenerative disease management.

This breakthrough highlights the potential for a safe and effective treatment that preserves brain function by protecting the blood-brain barrier, rather than solely targeting amyloid or neuronal damage. Further studies are underway to explore the drug's applicability in human clinical trials.

Source: https://medicalxpress.com/news/2025-05-potential-drug-blood-brain-barrier.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Multiple Chronic Conditions Significantly Increase Depression Risk, Study Finds

A recent study reveals that individuals with multiple chronic health conditions, especially combinations like diabetes and heart disease, face more than double the risk of developing depression. Integrated care approaches are essential to address this complex health challenge.

Advancing Diagnostic Tools for Childhood Speech Impairments Through Clinical AI

Innovative AI-driven diagnostic tools are being developed to facilitate early detection of speech impairments in children, overcoming dataset and resource challenges to improve pediatric speech therapy outcomes.